Specifically, mice deficient in DMP1-PG developed age-dependent osteopenia and had multiple metabolic defects in their osteoblasts, suggesting that DMP1 works in a similar way as Biglycan in modulating the activity of osteoblasts14. The gene discussed is DMP1; the disease is Osteopenia.